vTv Therapeutics VTVT
NASDAQ VTVT
$25.55 -1.61 (-5.93%)
At close: Oct 23, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Cash & Current Investments (2014 - 2026)

Updated

vTv Therapeutics (VTVT) recorded Cash & Current Investments of $86.64 million in Q2 2026, up 234.2% from $25.92 million a year earlier but down 11.7% from the prior quarter.

Analysis

vTv Therapeutics (VTVT) Cash & Current Investments (2014 - 2026) Analysis & Trends

At the end of FY2025, vTv Therapeutics reported Cash & Current Investments of $88.93 million, up 142.0% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 73.0% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $36.75 million in FY2024 (+289.0%), $9.45 million in FY2023 (-22.1%), $12.13 million in FY2022 (-9.6%) and $13.42 million in FY2021 (+133.4%).
  • Quarterly Cash & Current Investments has ranged from $8.24 million in Q3 2023 to $98.5 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 167.4% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 972.8% in Q3 2021, against a decline of 46.3% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $98.1 million (Q1 2026), $88.93 million (Q4 2025) and $98.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 vTv Therapeutics 317.06 Mn -55.12 Mn - 86.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86.64 Mn
Mar 31, 2026 98.10 Mn
Dec 31, 2025 88.93 Mn
Sep 30, 2025 98.50 Mn
Jun 30, 2025 25.92 Mn
Mar 31, 2025 31.10 Mn
Dec 31, 2024 36.75 Mn
Sep 30, 2024 41.60 Mn
Jun 30, 2024 45.53 Mn
Mar 31, 2024 52.30 Mn
Dec 31, 2023 9.45 Mn
Sep 30, 2023 8.24 Mn
Jun 30, 2023 12.60 Mn
Mar 31, 2023 18.80 Mn
Dec 31, 2022 12.13 Mn
Sep 30, 2022 15.34 Mn
Jun 30, 2022 17.90 Mn
Mar 31, 2022 12.14 Mn
Dec 31, 2021 13.42 Mn
Sep 30, 2021 19.60 Mn
API Access

vTv Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VTVT&period=max&api_key=YOUR_API_KEY